Roivant sold its stake in five subsidiaries (or "vants"), including Enzyvant, to Sumitomo Dainippon Pharma; Ramaswamy made $175 million in capital gains from the sale
Text from Wikipedia, available under CC BY-SA 4.0.
- #wikipedia
- #event
Roivant sold its stake in five subsidiaries (or "vants"), including Enzyvant, to Sumitomo Dainippon Pharma; Ramaswamy made $175 million in capital gains from the sale
Text from Wikipedia, available under CC BY-SA 4.0.
Captured 2026-08-17 from Wikipedia. The archived copy is preserved so this citation survives link rot.